Pharmaceutical Audit Readiness: Definition, Checklist, And Why It Matters

Pharmaceutical audit readiness is a continuous state of compliance in which a company’s systems, documentation, and personnel are consistently prepared for inspections by regulatory authorities such as the U.S. Food and Drug Administration, European Medicines Agency, Korea Food and Drug Administration, Pharmaceuticals and Medical Devices Agency, and World Health Organisation, as well as internal audit teams. It ensures ongoing adherence to GMP, GCP, and GLP standards through up-to-date documentation, a robust quality management system (QMS), and a proactive culture of quality and compliance.

Major Takeaway

Related: Regulatory Affairs

What is a Pharmaceutical Audit?

A pharmaceutical audit is a systematic and independent examination of pharmaceutical operations, systems, processes, or products to ensure compliance with regulatory requirements, internal standards, and industry best practices. These audits are crucial for maintaining quality, safety, and efficacy in pharmaceutical manufacturing and distribution.

Types of Pharmaceutical Audits:

1. Internal Audit: Conducted by the company’s own staff to monitor and improve internal processes.
2. External Audit:
   • Regulatory Audit: Carried out by government agencies (e.g., FDA inspection).
   • Customer Audit: Performed by clients or partners (e.g., a pharmaceutical company auditing a contract manufacturer).
   • Third-Party Audit: Conducted by independent organisations for certification purposes (e.g., ISO audits).

Why Audit Readiness Matters?

• Regulatory Compliance: Ensure compliance with regulatory bodies like the FDA (U.S.), EMA (Europe), MHRA (UK), etc.
• Patient Safety & Product Quality: It ensures Patient Safety & Product Quality
• Operational Efficiency: Verify adherence to Good Manufacturing Practices (GMP), Good Distribution Practices (GDP), and other standards. It also reduces downtime and improves workflows.
• Reputation Management: Demonstrates a reliable, high-quality manufacturing reputation to partners and regulators
• Continuous Improvement: Identify risks and areas for improvement.
• Prepare for inspections by regulatory authorities.

Key Elements for Maintaining Readiness

Audit readiness is no longer a point-in-time event but a continuous, proactive process.

• Mock Inspections: Conduct regular internal audits to identify and close compliance gaps before regulatory inspections.
• Digitalisation: Implement electronic systems (e.g., EDMS) to ensure real-time, accurate, and traceable documentation.
• Culture of Quality: Foster an environment where compliance is a daily responsibility, not a checklist activity.

• What Is the Difference Between an External Audit and an Internal Audit: Explained With FAQs

Areas Commonly Audited:

• Manufacturing processes
• Quality control laboratories
• Documentation and data integrity
• Storage and distribution
• Training and personnel qualifications
• Equipment calibration and maintenance
• Cleaning and validation procedures

Audit Outcomes:

• Compliance confirmed: No significant issues found.
• Observations: Minor issues that need correction.
• Non-conformities: Major issues requiring immediate corrective actions.
• Audit report: A formal document outlining findings, conclusions, and required actions.

14 Key Components of a Pharmaceutical Audit Checklist

1. General Information

• Date of audit
• Location/site
• Name and title of auditor(s)
• Name and title of person(s) interviewed

2. Facility and Equipment

• Clean, maintained, and calibrated equipment, proper environmental controls, and valid qualification documentation

3. Quality Management System (QMS)

• Is there a documented Quality Policy?
• Are responsibilities and roles clearly defined?
• Is there a current organisational chart?
• Are regular internal audits conducted?
• Are Corrective and Preventive Actions (CAPAs) tracked and documented?

4. Good Manufacturing Practices (GMP) Compliance

• Are facilities and equipment maintained per GMP standards?
• Are batch production records complete and reviewed?
• Are deviations documented and investigated?
• Are there change control procedures in place?

5. Documentation and Data Integrity

• Are all records completed in real-time, legible, and permanent?
• Are electronic systems validated and access-controlled?
• Are audit trails enabled for electronic records?
• Is there a record retention policy?

6. Manufacturing Processes

• Are SOPs (Standard Operating Procedures) in place and followed?
• Is the equipment cleaned and maintained?
• Are critical process parameters monitored and controlled?
• Are raw materials and APIs sourced from approved suppliers?

7. Quality Control (QC)

• Are analytical methods validated?
• Is the lab equipment calibrated regularly?
• Are out-of-specification (OOS) results investigated?
• Are stability studies conducted and documented?

8. Training and Personnel

• Are employees trained for their roles?
• Is training documented and up to date?
• Is there a system for ongoing GMP training?

9. Cleaning, Sanitation, and Contamination Control

• Are cleaning SOPs in place for the facility and equipment?
• Is there an environmental monitoring program?
• Are cleaning logs maintained?

10. Storage and Distribution (GDP Compliance)

• Are storage conditions (e.g. temperature, humidity) monitored?
• Are distribution records traceable?
• Are returned goods handled appropriately?

11. Validation and Qualification

• Is there a master validation plan?
• Are processes, cleaning, and equipment validated?
• Are utilities like water systems and HVAC validated?

12. Auditor Comments and Findings

• Action should be take in or before the time for any comments or findings

13. Supplier/Vendor Management

All vendors shall be qualified and approved as per the organisation’s SOP requirements, with documented evidence, including the approved vendor list and supplier audit reports, maintained and readily accessible.

14. Recommendations and Required Actions

The following schematic procedure should be adopted to complete the required actions:

• CAPA required? [ ] Yes [ ] No
• Responsible Person(s):
• Target Completion Date:
• Follow-up Date:

Related:

1. 7 Key Differences Between Audit and Inspection In The Pharmaceutical Industry: Learn In 3 minutes
2. How to Handle FDA Warning Letters: Common Causes, Key Challenges and Proven Solutions with Expert Tip
3. How to Handle FDA Warning Letters: Common Causes, Key Challenges and Proven Solutions with Expert Tips
4. What is FDA Certificate: Importance, Approval Process, Expert Tips & 5 FAQs
5. Form 483, Form 482, Form 484, EIR, OAI, NAI and VAI: Terms Related To FDA Inspection
6. Top 10 Audit-Ready Practices for Every QA & QC Professional

Pharmaceutical Audit: Interview Questions

What areas are typically reviewed during a pharmaceutical audit?

Key areas include:

• Manufacturing processes
• Quality Control (QC)
• Documentation and data integrity
• Equipment and facility maintenance
• Personnel training
• Storage and distribution

What are the common findings in a pharmaceutical audit?

Findings may include:

• Incomplete documentation
• Deviations not properly investigated
• Poor hygiene or cleaning practices
• Gaps in employee training
• Non-compliance with SOPs

How often should pharmaceutical audits be conducted?

• Internal audits are typically conducted annually or based on risk.
• External or customer audits may occur periodically or before supplier approval.
• Regulatory audits occur as scheduled or unannounced.

What documents should be ready for an audit?

• SOPs (Standard Operating Procedures)
• Batch records
• Validation protocols and reports
• Training records
• Equipment maintenance logs
• Quality manuals and audit reports

How can a company prepare for a pharmaceutical audit?

• Conduct regular internal audits
• Keep documentation complete and up-to-date
• Train staff continuously
• Address issues proactively through CAPA
• Maintain a state of constant readiness

Further Reading

• Types of FDA Inspection